← Clinical research
publishedregulation

Practical ICH-GCP

Apply ICH E6(R3) Good Clinical Practice to entry-level clinical-research decisions: protect participants, follow the approved protocol, preserve reliable data, escalate safety issues, document delegated work and respond proportionately when something goes wrong. This is practical GCP preparation for B.Pharm graduates moving toward site, coordinator, trial-assistant or monitoring work; it does not award, renew or impersonate an external GCP certificate.

Needed across

What you will be able to answer

A trial-site file shows consent signed after the first study procedure, a missed protocol visit, an SAE email that was not escalated, a corrected eCRF value with an unclear source and a coordinator performing work absent from the delegation log. What can you produce before the investigator and monitor review the case?

A GCP issue-triage brief that separates participant-rights and safety risks from protocol, data and record failures; maps each issue to the responsible investigator, sponsor or delegated role; identifies the contemporaneous evidence that must be preserved; states the immediate containment and escalation needed; and proposes proportionate corrective and preventive actions without inventing local reporting deadlines or replacing the approved protocol, SOPs and applicable Indian requirements.

Concepts
9
Selected clips
20m 41s
Employers use it
8

One payment

₹99

The videos are free

This is what you pay for

Compared → kept
29 → 9
Full videos → selected
2h 38m → 20m 41s
Concepts
9

Course outline

Learn from selected clips, concept by concept

Concept 1

Read GCP as two linked promises

free

Concept 1 · Read GCP as two linked promises

0:00 / 0:31

Concept 2

Map roles, delegation and oversight

locked

After: gcp-two-promises

A task can move to a coordinator, vendor or CRO; accountability and oversight do not disappear with it.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
49s kept
Video review
3 compared

Video title and channel appear once unlocked.

Concept 3

Use the protocol, and recognise a deviation

locked

After: roles-delegation-and-oversight

When trial conduct departs from the approved protocol, the first job is to protect the participant and preserve the facts—not relabel the event.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
1m 58s kept
Video review
3 compared

Video title and channel appear once unlocked.

Concept 4

Treat informed consent as an ongoing process

locked

After: protocol-compliance-and-deviations

A signature records consent; it does not prove that participation was informed, voluntary or still valid after circumstances change.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
2m 37s kept
Video review
2 compared

Video title and channel appear once unlocked.

Concept 5

Recognise and escalate serious safety events

locked

After: informed-consent-as-a-process

A non-clinical trial team member does not provide independent medical treatment; the job is to recognise the risk, route care, escalate promptly and preserve the facts.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
2m 46s kept
Video review
6 compared

Video title and channel appear once unlocked.

Concept 6

Control computerised systems across the data lifecycle

locked

After: participant-safety-and-escalation

A compliant platform is not defined by its brand; it is defined by controlled access, reliable operation and a reconstructable data lifecycle.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
1m 26s kept
Video review
3 compared

Video title and channel appear once unlocked.

Concept 7

Focus quality effort on what matters most

locked

After: protocol-compliance-and-deviations, computerised-systems-and-data-lifecycle

Good quality management concentrates prevention and oversight where errors would meaningfully harm participants or make the result unreliable.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
5m 52s kept
Video review
3 compared

Video title and channel appear once unlocked.

Concept 8

Respond to noncompliance without hiding the event

locked

After: quality-by-design-and-proportionate-risk

A defensible CAPA contains the immediate risk, explains why the failure occurred and tests whether recurrence was actually prevented.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
2m 56s kept
Video review
3 compared

Video title and channel appear once unlocked.

Concept 9

Let essential records reconstruct the trial

locked

After: roles-delegation-and-oversight, noncompliance-root-cause-and-capa

Inspection readiness is the ability to reconstruct how the trial protected participants and produced its result—not a clean-up sprint before an audit.

Selected range
▮▮:▮▮ → ▮▮:▮▮
Clip retained
1m 20s kept
Video review
3 compared

Video title and channel appear once unlocked.

Selection criteria

  • Applies ICH E6(R3) to a clinical-trial decision, document, data change or participant interaction
  • Connects participant protection and reliable results rather than teaching either ethics or documentation in isolation
  • Makes responsibility, escalation and evidence visible through a realistic site, sponsor, CRO or data-management example
  • Distinguishes ICH principles from protocol, SOP and applicable local regulatory requirements
  • Avoids certificate-test coaching, regulation-number memorisation and software-only demonstrations

What was rejected

15 candidates did not meet the course criteria.

  • Presents GCP as academic syllabus points for pharmacy students rather than explicitly framing and linking them as mutual promises with applied clinical decision scenarios.
  • Lacks a comparative scenario covering sponsor and IRB/IEC roles, and does not address task delegation procedures or delegation logs.
  • Informal vlog format lacking formal slides, protocol excerpts, or a step-by-step clinical trial walkthrough.
  • The video is a brief webinar promo slide overview and lacks detailed examples or instructional depth.
  • Focuses heavily on initial enrollment and consent form elements rather than detailing re-consent procedures, LARs, or ongoing consent management during trial conduct.
  • Only teaches AE and SAE definitions
  • Only teaches AE and SAE definitions
  • presents one reporting clock as universal across all protocols and jurisdictions
  • omits the investigator or sponsor escalation path
  • omits the investigator or sponsor escalation path
  • High-level synthetic summary of ICH E6(R3) modernization that lacks technical depth on specific validation, audit trail, or access control procedures.
  • Provides a high-level overview of quality management systems rather than a concrete noncompliance case study.
  • Is generic manufacturing CAPA
  • Does not walk through an inspection or trial scenario demonstrating how essential documents reconstruct trial conduct, participant safety, or protocol adherence.
  • Is only a TMF filing taxonomy or Veeva navigation tutorial

Where this skill is used

Clinical research

You help run the trials that test new medicines. You visit study sites to check that the data is correct and the rules are followed. Later, you manage whole trials. Pay grows well and the work matters a lot. The main downside is travel.

8 mapped employers

Explore path →